Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Glomerulosclerosis”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableLooking for participantsNCT02986984
What this trial is testing

Transformative Research in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathiesDiabetic Glomerulosclerosis
University of Pennsylvania 400
Early research (Phase 1)Study completedNCT03970122
What this trial is testing

FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Goldfinch Bio, Inc. 70
Post-approval studies (Phase 4)UnknownNCT00328302
What this trial is testing

Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy

Who this might be right for
Diabetes, Type I
Karolinska University Hospital 13
Not applicableStudy completedNCT00255398
What this trial is testing

Kidney Disease Biomarkers

Who this might be right for
Kidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Not applicableStudy completedNCT04389827
What this trial is testing

Global Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
The George Institute 5,999
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Testing effectiveness (Phase 2)Ended earlyNCT04387448
What this trial is testing

TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Who this might be right for
Kidney DiseasesDiabetic NephropathiesGlomerulosclerosis, Focal Segmental+8 more
Goldfinch Bio, Inc. 96
Not applicableLooking for participantsNCT06760845
What this trial is testing

Raman Spectroscopy Diagnosis of Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Membranous NephropathyDiabetic Nephropathy+1 more
Zunsong Wang 200
Testing effectiveness (Phase 2)Ended earlyNCT01113801
What this trial is testing

A Study in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis
Eli Lilly and Company 417
Not applicableEnded earlyNCT04235621
What this trial is testing

Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseDiabetic Nephropathies
Goldfinch Bio, Inc. 20
Not applicableLooking for participantsNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Post-approval studies (Phase 4)Ended earlyNCT01129557
What this trial is testing

Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Who this might be right for
Proteinuric Kidney DiseaseDiabetic NephropathyHypertensive Nephrosclerosis+4 more
Columbia University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04573920
What this trial is testing

Atrasentan in Patients With Proteinuric Glomerular Diseases

Who this might be right for
IgA NephropathyFocal Segmental GlomerulosclerosisAlport Syndrome+3 more
Novartis Pharmaceuticals 103
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13